Clinical Trial Update: Procalcitonin to Shorten Antibiotics Duration in ICU Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether using procalcitonin levels to guide antibiotic duration reduces antibiotic exposure in ICU patients with sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Procalcitonin-guided antibiotic therapy (procalcitonin-guided antibiotic therapy)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Sepsis | Phase 3 | Status: UNKNOWN